Premium
Front Cover: Dose‐Dependent Effects of Royal Jelly on Estrogen‐ and Progesterone‐Induced Mammary Gland Hyperplasia in Rats
Author(s) -
Liu Yibing,
Wu Dequn,
Wang Kang,
Chen Heng,
Xu Hao,
Zong Wencheng,
Zhang Nan,
Zhao Luan,
Lin Zheguang,
Ji Ting
Publication year - 2022
Publication title -
molecular nutrition and food research
Language(s) - English
Resource type - Reports
SCImago Journal Rank - 1.495
H-Index - 131
eISSN - 1613-4133
pISSN - 1613-4125
DOI - 10.1002/mnfr.202270013
Subject(s) - royal jelly , hyperplasia , mammary gland , estrogen , medicine , endocrinology , endocrine system , front cover , biology , hormone , cover (algebra) , breast cancer , cancer , food science , mechanical engineering , engineering
Mol. Nutr. Food Res . 2022, 66 , 202100355 DOI: 10.1002/mnfr.202100355 Royal jelly (RJ) is obtained from honeybee queen cells. In article number 2100355, Liu and co‐workers used RJ on hyperplasia of the mammary gland (HMG) in rats. RJ is demonstrated to participate in regulating the hypothalamus‐pituitary‐ovarian axis, subside endocrine dyscrasia induced by estrogen and progesterone, and alleviate the hyperplasia of breast tissue, implying great potential in the prevention and treatment of HMG.